AEON Biopharma, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AEON research report →
Companywww.aeonbiopharma.com
AEON Biopharma, Inc. , a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis.
- CEO
- Robert Bancroft
- IPO
- 2023
- Employees
- 5
- HQ
- Newport Beach, CA, US
Price Chart
Valuation
- Market Cap
- $10.21M
- P/E
- -0.17
- P/S
- 0.00
- P/B
- -0.62
- EV/EBITDA
- -0.36
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 223.66%
- ROIC
- -823.75%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-39,222,000 · -193.37%
- EPS
- $-3.95 · -105.08%
- Op Income
- $-12,803,000
- FCF YoY
- 14.69%
Performance & Tape
- 52W High
- $1.45
- 52W Low
- $0.46
- 50D MA
- $0.98
- 200D MA
- $0.95
- Beta
- 0.66
- Avg Volume
- 103.46K
Get TickerSpark's AI analysis on AEON
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 2, 26 | Bencich John | other | 754,717 |
| Apr 1, 26 | Bencich John | other | 0 |
| Mar 4, 26 | Oh Chad | other | 1,316,872 |
| Feb 17, 26 | Oh Chad | other | 862,500 |
| Mar 4, 26 | Wilson Alexander Blair | other | 1,316,872 |
| Feb 17, 26 | Wilson Alexander Blair | other | 862,500 |
| Mar 4, 26 | Sy Jennifer | other | 925,925 |
| Feb 17, 26 | Sy Jennifer | other | 575,000 |
| Feb 17, 26 | Bancroft Robert E. | other | 3,000,000 |
| Jan 21, 26 | Daewoong Co., Ltd | other | 0 |
Our AEON Coverage
We haven't published any research on AEON yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AEON Report →